Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

To Survive After ICU Discharge

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02599636
Recruitment Status : Unknown
Verified July 2016 by Silvia Cano Hernández, Althaia Xarxa Assistencial Universitària de Manresa.
Recruitment status was:  Active, not recruiting
First Posted : November 6, 2015
Last Update Posted : July 14, 2016
Sponsor:
Information provided by (Responsible Party):
Silvia Cano Hernández, Althaia Xarxa Assistencial Universitària de Manresa

Brief Summary:

Many factors before and after ICU stay determine the outcome of patients at ICU discharge, the type of illness, physical dependence and other sequelae can be a trigger for complications in hospital ward which can induce ICU readmission and worse outcome. The quality of medical assistance during all the hospitalisation should be guaranteed and many complications or fatal events could be avoidable.

The objective of the present study is to demonstrate that collaboration between the intensivist and other medical teams in ward can reduce ICU readmission and hospital mortality after ICU discharge.


Condition or disease Intervention/treatment
In-Hospital Mortality Number of ICU Readmission Number of Warnings On-duty Other: None intervention

Detailed Description:

Material and Methods This observational multicenter study will be done in 21 medical-surgical ICUs. We will use Sabadell Score like prognostic scale at ICU discharge and the intensivist will collaborate with the medical team in medical assistance of patients at risk (Sabadell Score 1 and 2). Investigators will compare the hospital mortality and the readmission rate with a previous period when this collaboration didn't exist.

Anticipate results The collaboration of attending intensivist might reduce ward mortality after ICU discharge by 3%.


Layout table for study information
Study Type : Observational
Estimated Enrollment : 1200 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Multicenter Prospective Study: To Survive After ICU Discharge
Study Start Date : October 2015
Estimated Primary Completion Date : September 2016
Estimated Study Completion Date : September 2016

Intervention Details:
  • Other: None intervention
    Investigators will study the usual medical assistance


Primary Outcome Measures :
  1. The decline in hospital mortality [ Time Frame: 3 months ]

Secondary Outcome Measures :
  1. The decline in number of warnings on-duty [ Time Frame: 3 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 99 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients at ICU discharge
Criteria

Inclusion Criteria:

  • All patients with Sabadell Score 1 (poor prognosis in long term) and 2 (poor prognosis in short term) at ICU discharge

Exclusion Criteria:

  • patients younger than 18 years old
  • patients with Sabadell Score 0 (good prognosis)
  • patients with Sabadell Score 3 (null expected survival)
  • patients transferred to other hospitals

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02599636


Locations
Layout table for location information
Spain
Althaia Xarxa Assistencial Universitaria de Manresa
Manresa, Barcelona, Spain, 08243
Sponsors and Collaborators
Althaia Xarxa Assistencial Universitària de Manresa
Investigators
Layout table for investigator information
Principal Investigator: Silvia Cano Hernández, Physician Althaia Xarxa Assistencial Universitaria de Manresa

Layout table for additonal information
Responsible Party: Silvia Cano Hernández, Physician, Althaia Xarxa Assistencial Universitària de Manresa
ClinicalTrials.gov Identifier: NCT02599636     History of Changes
Other Study ID Numbers: Althaia
First Posted: November 6, 2015    Key Record Dates
Last Update Posted: July 14, 2016
Last Verified: July 2016